These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6122155)

  • 1. Processing of synthetic somatostatin-28 and a related endogenous rat hypothalamic somatostatin-like molecule by hypothalamic enzymes.
    Zingg HH; Patel YC
    Life Sci; 1982 Feb; 30(6):525-33. PubMed ID: 6122155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing of somatostatin-28 to somatostatin-14 by rat hypothalamic synaptosomal membranes.
    Zingg HH; Patel YC
    Life Sci; 1983 Sep; 33(13):1241-7. PubMed ID: 6136883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture.
    Zingg HH; Patel YC
    J Clin Invest; 1982 Nov; 70(5):1101-9. PubMed ID: 7130395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic metabolism of somatostatin-14 and somatostatin-28: immunochemical characterization of the metabolic fragments and comparison of cleavage sites.
    Ruggere MD; Patel YC
    Endocrinology; 1985 Jul; 117(1):88-96. PubMed ID: 2861082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high molecular weight form of somatostatin-28 (1-12)-like immunoreactive substance without somatostatin-14 immunoreactivity in the rat pancreas. Evidence that somatostatin-14 synthesis can occur independently of somatostatin-28.
    Patel YC
    J Clin Invest; 1983 Dec; 72(6):2137-43. PubMed ID: 6139388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M; Kronheim S; Pimstone B; Shapiro B
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity.
    McIntosh CH; Bakich V; Bokenfohr K; DiScala-Guenot D; Kwok YN; Brown JC
    Regul Pept; 1988 Jun; 21(3-4):205-18. PubMed ID: 2901134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional distribution of somatostatin-like immunoreactivity in the human brain.
    Geola FL; Yamada T; Warwick RJ; Tourtelotte WW; Hershman JM
    Brain Res; 1981 Dec; 229(1):35-42. PubMed ID: 6118202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hypophysectomy on somatostatin-like immunoreactivity in discrete hypothalamic and extrahypothalamic nuclei.
    Terry LC; Crowley WR
    Endocrinology; 1980 Dec; 107(6):1771-5. PubMed ID: 6107243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple forms of somatostatin-like immunoreactivity in the hypothalamus and amygdala of the rat: selective localization of somatostatin-28 in the median eminence.
    Pierotti AR; Harmar AJ
    J Endocrinol; 1985 Jun; 105(3):383-9. PubMed ID: 2860197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to the study of somatostatin biosynthesis.
    Zingg HH; Habener JF; Patel YC
    Adv Exp Med Biol; 1985; 188():49-58. PubMed ID: 2863949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin-like immunoreactivity (SLI) in pancreatic and intestinal tissues of the duck. A possible origin for the portal circulating SLI.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    Horm Metab Res; 1985 Nov; 17(11):566-71. PubMed ID: 2867025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone-releasing factor immunoreactivity in the hypothalamus and cortex of the rat: in vivo and in vitro studies.
    Leidy JW; Robbins RJ
    Endocrinology; 1988 Apr; 122(4):1652-7. PubMed ID: 3126041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for somatostatin precursors in human stomach, placenta, and amniotic fluid.
    Fitz-Patrick D; Patel YC
    J Clin Endocrinol Metab; 1981 Aug; 53(2):372-6. PubMed ID: 6114109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin-like immunoreactivity in mammalian thyroid glands: contents and partial characterization.
    Oyama H; Kameda Y; Endoh M; Nagase Y; Matsuki M; Kakita K; Tenku A; Nishida S; Horino M
    Endocrinology; 1984 Mar; 114(3):1028-32. PubMed ID: 6141931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog.
    Polonsky KS; Jaspan JB; Berelowitz M; Emmanouel DS; Dhorajiwala J
    J Clin Invest; 1981 Nov; 68(5):1149-57. PubMed ID: 6117570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine.
    Sagar SM; Landry D; Millard WJ; Badger TM; Arnold MA; Martin JB
    J Neurosci; 1982 Feb; 2(2):225-31. PubMed ID: 6121016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin metabolism by the isolated rat lung.
    Ruggere MD; Patel YC
    Endocrinology; 1985 Nov; 117(5):1870-3. PubMed ID: 2864236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired hepatic metabolism of somatostatin-14 and somatostatin-28 in spontaneously diabetic BB rats.
    Ruggere MD; Patel YC
    Endocrinology; 1984 Jul; 115(1):244-8. PubMed ID: 6145581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin metabolism: differences in clearance of N-terminal and central portions of molecule during perfusion of rat liver.
    Sacks HS; Terry LC; Wright RK; Stentz FB
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G226-34. PubMed ID: 6142653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.